GBI (formerly Goodwin Biotechnology) is a full-service development CDMO offering a single-source solution for biologics manufacturing at all stages — from process tech transfer and scale-up to cGMP production of bulk drug substance and vialed drug product — for preclinical, clinical, and commercial use. The South Florida–based company recently inaugurated a 38,000-sq.-ft. manufacturing and process development facility equipped for cGMP commercial operations.
